• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

The Dawn of the Intelligence Age: How AI is Transforming Science and Medicine

user avatar

by Giorgi Kostiuk

2 years ago


On September 23, Sam Altman, co-founder and CEO of OpenAI, released an essay declaring the arrival of the “Intelligence Age.” Altman claims that AI will lead to exponential advancements including climate solutions and discoveries in physics. Despite criticism, AI is already being utilized in various scientific fields and medicine, accelerating research and improving healthcare services.

Artificial Intelligence in Ultrasound Imaging

GE Verisound AI employs proprietary software to assist non-experts in capturing high-quality ultrasound images of the heart, aiding in earlier disease detection. One of the company's main offerings, Caption AI, provides real-time visual guidance and quality measurement to ensure high-resolution images. The AutoEF feature, driven by AI algorithms, calculates critical heart health metrics such as the left ventricular ejection fraction.

AI in Drug Discovery

San Francisco-based Atomwise uses AI to accelerate the drug discovery process. Their AtomNet platform utilizes convolutional neural networks to predict the efficacy of potential drug candidates before costly clinical trials. By analyzing experimental affinity measurements and protein structures, AtomNet speeds up the identification of safe and effective drug candidates, significantly reducing the time and cost of bringing new medicines to market. In April 2024, Atomwise successfully identified novel drug candidates for 235 out of 318 targets.

The Role of AI in Radiology

Behold.ai is developing AI-assisted radiology with its “red dot” algorithm, which classifies chest X-rays and localizes findings as heat maps using deep learning models. The algorithm achieves 90% accuracy in detecting abnormalities within seconds, reducing radiologists' workloads and diagnosis wait times. Similarly, Enlitic uses deep learning to interpret medical images, enabling the detection of malignant lung nodules up to 18 months before a biopsy.

AI is playing a significant role in scientific research and medical advancements. Its applications, from ultrasound imaging to drug discovery and medical image interpretation, highlight its tremendous potential to improve healthcare and accelerate scientific progress.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Farside Investors Emphasizes Strict Editorial Standards

chest

Farside Investors has released a report that emphasizes its commitment to a strict editorial policy focused on accuracy, relevance, and impartiality.

user avatarNguyen Van Long

Meta is Set to Launch a New Prediction Market App Named 'Arena'

chest

Meta is reportedly developing a new app called Arena that will allow users to make predictions on events using points instead of real-world cash.

user avatarJesper Sørensen

Meta's Previous Ventures into Crypto and Prediction Markets

chest

Meta has a history of engaging with crypto technologies, including its previous attempt at a prediction market with the Forecast app, which was launched in 2020 and shelved in 2022.

user avatarSatoshi Nakamura

TurboFlow Secures $6 Million Seed Funding from Pantera Capital

chest

TurboFlow has successfully raised $6 million in a seed funding round led by Pantera Capital, indicating strong investor interest in platforms that integrate prediction markets and trading infrastructure.

user avatarRajesh Kumar

Securitize and tZERO Enter Legal Battle Over Tokenized Securities

chest

Securitize and tZERO are currently engaged in a legal dispute in Delaware concerning the infrastructure for tokenized securities.

user avatarLucas Weissmann

Ted Pillows Releases New Report on Liquidation Data

chest

Ted Pillows has released a new report based on liquidation data, offering valuable insights into current financial trends.

user avatarFilippo Romano

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.